January 2022

Deepbridge Capital has recently been featured in the first issue of GB Investments Magazine for 2022. 

Aegiq, a University of Sheffield spin-out developing networking technology that's secure in the quantum computing age, has raised £1.8 million in seed funding for its quantum photonics platform. 

Deepbridge Capital and angel investors provided funds alongside High-Tech Gründerfonds, bringing Aegiq's total funding to date to £3.5 million. Aegiq is also considering funds to join a second seed round of funding. 

One of the world's largest global wealth managers, UBS, has partnered with Fund Her North, working to improve access to finance for female-led businesses. 

Fund Her North is made up of over 28 women in venture capital, including Samantha Piddington (Head of Corporate Finance - Deepbridge Capital), funding organisations and angel groups with a combined investment power of over £450m. 

The Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS usually deploy funds on a monthly basis, with numerous deployments expected between now and the 5th April 2022.   

Deepbridge has today (19 January 2022) announced that Pathfinder Medical, a portfolio company within the Deepbridge Life Sciences EIS fund has secured a further £8.5 million funding round, led by BGF and Parkwalk.  

One of Deepbridge's award-winning, leading European Cloud Software Technology Growth EIS Companies, Sardina Systems, has announced the opening of a new subsidiary in Luxembourg. 

We are delighted to announce that we are the headline sponsor for Northcote's Obsession 2022 gourmet food festival. 

We are pleased to announce the launch of our brand new Deepbridge Discovery Podcast. 

As of today (12th January 2022), we are happy to announce that the Deepbridge Capital Technology Growth EIS Fund has now deployed over £100m of capital. 

Cardiff Health Tech Firm, Glucose Republic has now closed a £500,000 investment round from Deepbridge Capital and the Development Bank of Wales, to build a system focused on what impact food has by combining biology and software.

GBI Magazine recently spoke to Sameer Kothari, Chief Executive Director of Zilico Ltd, to talk about his Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.  

Recently, GBI Magazine sat down with FluoretiQ Co-Founder & CEO, Neciah Dorh, to talk about his Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.  

GBI Magazine recently spoke to Dr Caroline Barelle, CEO & Founder of Elasmogen, to talk about her Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.